OVERVIEW
Multiple treatment options today provide the opportunity of improved outcomes for many patients diagnosed with metastatic hormone-sensitive prostate cancer (mHSPC), or metastatic castration-resistant prostate cancer (mCRPC). With the growing number of efficacious therapies inevitably comes complexity in treatment planning. In this live symposium, experts in the care of patients with prostate cancer will utilize case studies to outline the selection of systemic therapy guided by cytogenetic or molecular testing and the appropriate follow-up using various tumor imaging modalities and/or biomarker assessment, outline emerging clinical data, and discuss understanding and prioritizing working as a multidisciplinary team to develop and institute care plans for patients with mCRPC or mHSPC.
GOAL STATEMENT
The goal of this activity is for learners to be better able to care for patients with prostate cancer using novel therapies and to utilize the multidisciplinary team approach to enhance prostate cancer management.
LEARNING OBJECTIVES
Upon completion of this activity, participants will: [LIST] [ITEM]Determine the biological rationale of the utilization of therapies in patients with metastatic castration-resistant prostate cancer (mCRPC) or metastatic hormone-sensitive prostate cancer (mHSPC) [ITEM]Recognize patients with high-risk mHSPC [ITEM]Summarize emerging clinical data associated with novel therapies for patients with mCRPC and mHSPC [ITEM]Prioritize working as a multidisciplinary team to develop and institute a care plan for patients with mCRPC or mHSPC [ITEM]Understand the role of each member of the multidisciplinary team [/LIST]
ACCREDITATION STATEMENT
[MEDSCAPE] [JALOGO] In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
[bold] For Physicians [/bold] Medscape, LLC designates this live activity for a maximum of 1.0 [bold] [italic] AMA PRA Category 1 Credits™[/italic] [/bold]. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Omni Shoreham Hotel
Room: Palladian Room
2500 Calvert St NW
Washington, DC, 20008
United States
Symposium in conjunction with the SUO.
Supported by an independent educational grant from Lilly.